CN113854562A - Soft capsule of sweet almond oil and preparation method - Google Patents
Soft capsule of sweet almond oil and preparation method Download PDFInfo
- Publication number
- CN113854562A CN113854562A CN202110952829.1A CN202110952829A CN113854562A CN 113854562 A CN113854562 A CN 113854562A CN 202110952829 A CN202110952829 A CN 202110952829A CN 113854562 A CN113854562 A CN 113854562A
- Authority
- CN
- China
- Prior art keywords
- sweet almond
- almond oil
- soft capsule
- omega
- sweet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000144725 Amygdalus communis Species 0.000 title claims abstract description 137
- 235000011437 Amygdalus communis Nutrition 0.000 title claims abstract description 137
- 239000008168 almond oil Substances 0.000 title claims abstract description 108
- 239000007901 soft capsule Substances 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 69
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 42
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 42
- 239000002775 capsule Substances 0.000 claims abstract description 39
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims abstract description 37
- 108010010803 Gelatin Proteins 0.000 claims abstract description 33
- 229920000159 gelatin Polymers 0.000 claims abstract description 33
- 239000008273 gelatin Substances 0.000 claims abstract description 33
- 235000019322 gelatine Nutrition 0.000 claims abstract description 33
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 33
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 27
- 239000000944 linseed oil Substances 0.000 claims abstract description 27
- 235000011187 glycerol Nutrition 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 238000003825 pressing Methods 0.000 claims description 34
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 18
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 18
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 18
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 18
- 238000002791 soaking Methods 0.000 claims description 18
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 16
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 15
- 239000010779 crude oil Substances 0.000 claims description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000007670 refining Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 9
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 9
- 229960004488 linolenic acid Drugs 0.000 claims description 9
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000006014 omega-3 oil Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000011257 shell material Substances 0.000 claims 6
- 238000011161 development Methods 0.000 abstract description 22
- 230000009286 beneficial effect Effects 0.000 abstract description 16
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 14
- 235000020778 linoleic acid Nutrition 0.000 abstract description 14
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 14
- 235000020665 omega-6 fatty acid Nutrition 0.000 abstract description 12
- 229940033080 omega-6 fatty acid Drugs 0.000 abstract description 12
- 210000004027 cell Anatomy 0.000 abstract description 5
- 102000004895 Lipoproteins Human genes 0.000 abstract description 3
- 108090001030 Lipoproteins Proteins 0.000 abstract description 3
- 210000002390 cell membrane structure Anatomy 0.000 abstract description 3
- 230000014509 gene expression Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000000643 oven drying Methods 0.000 description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- 230000037208 balanced nutrition Effects 0.000 description 3
- 235000019046 balanced nutrition Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229960005150 glycerol Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/008—Refining fats or fatty oils by filtration, e.g. including ultra filtration, dialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Edible Oils And Fats (AREA)
Abstract
The invention discloses a sweet almond oil soft capsule and a preparation method thereof, relating to the technical field of soft capsules. The sweet almond oil soft capsule comprises a capsule shell and an inclusion compound wrapped in the capsule shell, wherein the capsule shell is made of gelatin, glycerol and omega-3 fatty acid, and the inclusion compound comprises sweet almond oil and linseed oil. Omega-3 fatty acid is added into the capsule shell of the soft capsule, the omega-3 fatty acid can interact with omega-6 fatty acid linoleic acid in the sweet almond oil to jointly regulate the growth and development of human bodies, the dynamic balance of the omega-3 fatty acid and the linoleic acid is beneficial to the stable and normal growth and development of the internal environment and the function of the human bodies, and the omega-3 fatty acid and the linoleic acid can also maintain the stable cell membrane structure, regulate gene expression and maintain the balance of cell factors and lipoprotein. The sweet almond oil soft capsule provided by the invention is beneficial to the growth and development of human bodies and can maintain the dynamic balance in the human bodies.
Description
Technical Field
The invention relates to the technical field of soft capsules, in particular to a sweet almond oil soft capsule and a preparation method thereof.
Background
Sweet almond oil is a neutral base oil, is rich in oleic acid and linoleic acid, is one of the most widely used vegetable oils, is light yellow, is milder and is popular with consumers.
The sweet almond oil is used as an oil product, wherein unsaturated fatty acids mainly comprise oleic acid and linoleic acid, the linoleic acid is omega-6 fatty acid, and the unsaturated fatty acids are single in type and are not beneficial to growth and development of a human body.
Disclosure of Invention
The invention mainly aims to provide a sweet almond oil soft capsule and a preparation method thereof, aiming at providing the sweet almond oil soft capsule which is beneficial to the growth and development of human bodies and the dynamic balance in vivo.
In order to achieve the purpose, the invention provides a sweet almond oil soft capsule which comprises a capsule shell and an inclusion compound wrapped in the capsule shell, wherein the capsule shell is made of gelatin, glycerol and omega-3 fatty acid, and the inclusion compound comprises sweet almond oil.
Optionally, the ratio of the amount of the sweet almond oil to the amount of the omega-3 fatty acid is (30-45): 1.
optionally, the omega-3 fatty acid comprises at least one of linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid.
Optionally, the gelatin is an edible gelatin; and/or the presence of a gas in the gas,
the mass ratio of the gelatin to the glycerol is (5-10): (2-4).
Optionally, the material of the capsule shell further comprises starch; and/or the presence of a gas in the gas,
the capsule shell also comprises organic calcium.
Optionally, the sweet almond oil is cold-pressed sweet almond oil.
The invention further provides a preparation method of the sweet almond oil soft capsule, which comprises the following steps:
s10, putting the gelatin into water to be soaked and expanded, adding other raw materials of the capsule shell, stirring uniformly, and performing vacuum defoamation to obtain a mixture;
s20, pressing the mixture at 70-80 ℃ to prepare a soft film;
s30, pressing the soft capsule, the sweet almond oil and the linseed oil into soft capsules.
Optionally, in step S10, the vacuum degree of the vacuum defoaming is-0.06 to-0.07 MPa; and/or the presence of a gas in the gas,
the vacuum defoaming time is 1-2 h.
Optionally, in step S30, the sweet almond oil is prepared by:
s31, soaking the sweet almonds in water, rubbing the sweet almonds into skins, and cleaning the skins to obtain peeled sweet almonds;
s32, drying the peeled sweet almonds at 40-60 ℃, and performing cold pressing to obtain crude oil;
s33, filtering and refining the crude oil to obtain the sweet almond oil.
Optionally, the cold pressing temperature is 40-50 ℃.
In the technical scheme, the invention provides a sweet almond oil soft capsule, wherein omega-3 fatty acid is added into a capsule shell of the soft capsule, the omega-3 fatty acid can interact with omega-6 fatty acid linoleic acid in the sweet almond oil to jointly regulate the growth and development of a human body, the dynamic balance of the omega-3 fatty acid and the omega-6 fatty acid linoleic acid is favorable for the stable environment and function and the normal growth and development of the human body, the stable cell membrane structure can be maintained, the gene expression is regulated, and the balance of cell factors and lipoprotein is maintained, in addition, the inclusion compound also comprises linseed oil, the main nutrient components of the linseed oil are linoleic acid and linolenic acid, the function of supplementing the omega-3 fatty acid and the omega-6 fatty acid is realized, and the health of the human body is further facilitated. The sweet almond oil soft capsule provided by the invention has balanced nutrition, is beneficial to the growth and development of human bodies, and can maintain the dynamic balance in the human bodies.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the structures shown in the drawings without creative efforts.
Fig. 1 is a schematic flow chart of an embodiment of a method for preparing a sweet almond oil soft capsule provided by the invention.
The implementation, functional features and advantages of the objects of the present invention will be further explained with reference to the accompanying drawings.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It should be noted that, if directional indications (such as upper, lower, left, right, front, rear, outer and inner … …) are involved in the embodiment of the present invention, the directional indications are only used to explain the relative position relationship between the components, the motion situation, etc. in a specific posture (as shown in the drawing), and if the specific posture is changed, the directional indications are changed accordingly.
In addition, if there is a description of "first", "second", etc. in an embodiment of the present invention, the description of "first", "second", etc. is for descriptive purposes only and is not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one such feature. In addition, the meaning of "and/or" appearing throughout includes three juxtapositions, exemplified by "A and/or B" including either A or B or both A and B. In addition, technical solutions between various embodiments may be combined with each other, but must be realized by a person skilled in the art, and when the technical solutions are contradictory or cannot be realized, such a combination should not be considered to exist, and is not within the protection scope of the present invention.
The sweet almond oil is used as an oil product, wherein unsaturated fatty acids mainly comprise oleic acid and linoleic acid, the linoleic acid is omega-6 fatty acid, and the unsaturated fatty acids are single in type and are not beneficial to growth and development of a human body.
In view of this, the invention provides a sweet almond oil soft capsule, aiming at providing a sweet almond oil soft capsule which is beneficial to the growth and development of human body and the dynamic balance in vivo. In the attached drawings, fig. 1 is a schematic flow chart of an embodiment of a preparation method of a sweet almond oil soft capsule provided by the invention.
The invention provides a sweet almond oil soft capsule which comprises a capsule shell and an inclusion compound wrapped in the capsule shell, wherein the capsule shell is made of gelatin, glycerol and omega-3 fatty acid, and the inclusion compound comprises sweet almond oil.
The soft sweet almond oil capsule provided by the invention is characterized in that omega-3 fatty acid is added into the capsule shell of the soft sweet almond oil, the omega-3 fatty acid can interact with omega-6 fatty acid linoleic acid in the sweet almond oil to jointly regulate the growth and development of a human body, the dynamic balance of the omega-3 fatty acid and the omega-6 fatty acid linoleic acid is beneficial to the stable environment and the functional stability and the normal growth and development of the human body, the stable cell membrane structure can be maintained, the gene expression can be regulated, and the balance of cell factors and lipoprotein can be maintained. The sweet almond oil soft capsule provided by the invention has balanced nutrition, is beneficial to the growth and development of human bodies, and can maintain the dynamic balance in the human bodies.
Researches show that about 20 percent of linoleic acid is contained in the sweet almond oil, the linoleic acid is omega-6 fatty acid, and in order to ensure that a human body obtains balanced unsaturated fatty acid, in the embodiment of the invention, the omega-3 fatty acid is added into the capsule shell of the sweet almond oil soft capsule, and the omega-3 fatty acid is necessary nutrition for human, can promote the reduction of triglyceride, is beneficial to heart health, and has treatment effect on various diseases of the human body. Research also shows that omega-3 fatty acid can help other conditions, namely rheumatoid arthritis, depression and other diseases, but cannot be synthesized in human body per se and must be obtained from food, and the omega-3 fatty acid and omega-6 fatty acid linoleic acid interact to jointly regulate the growth and development of the human body, thereby solving the problems that the unsaturated fatty acid type is single and is not beneficial to the growth and development of the human body.
In addition, in the embodiment of the invention, the omega-3 fatty acid and the sweet almond oil are respectively arranged in the capsule shell and the inclusion compound of the sweet almond oil soft capsule, and after entering the human body, the omega-3 fatty acid and the sweet almond oil meet each other and are absorbed by the human body at the same time, so that the absorption efficiency can be improved, the growth and development of the human body can be facilitated, and the dynamic balance in the human body can be maintained.
The ratio of the linseed oil to the sweet almond oil is not limited in the present invention, and preferably, the mass ratio of the linseed oil to the sweet almond oil is 1: (0.5-4), and in the range, the proportion of omega-3 fatty acid and omega-6 fatty acid in the soft capsule is uniform, so that the soft capsule is more beneficial to the growth and development of a human body and can maintain the dynamic balance in the human body.
The ratio of the sweet almond oil to the omega-3 fatty acid is not limited in the invention, and preferably, the ratio of the amounts of the sweet almond oil to the omega-3 fatty acid is (30-45): 1. the ratio of the amount of the omega-6 fatty acid to the amount of the omega-3 fatty acid taken by a human body is (6-9): 1, thus being more beneficial to regulating the growth and development of the human body and maintaining the stability of the internal and the function of the human body.
Further, the omega-3 fatty acid comprises at least one of linolenic acid, eicosapentaenoic acid and docosahexaenoic acid. Eicosapentaenoic acid (EPA) contains 5 unsaturated bonds, is commonly called as brain gold, is a main element for the growth and maintenance of nervous system cells, and is also an important constituent of the brain and retina; docosahexaenoic acid (DHA) is the main component of fish oil, and has irreplaceable effects in dredging and clearing cardiovascular system; linolenic acid exists in deep green plants in the form of glyceride, is a main component constituting human tissue cells, cannot be synthesized and metabolized in vivo, and is converted into vital active factors DHA and EPA necessary for the organism.
The omega-3 fatty acid adopted by the invention can be any one of the three, and also can be any two or three of the three, and more preferably, the omega-3 fatty acid comprises at least one of eicosapentaenoic acid and docosahexaenoic acid, thus being more beneficial to the growth and development of human bodies.
In addition, preferably, the gelatin is edible gelatin, the edible gelatin is processed by utilizing collagen of bones and skins of animals such as pigs, cows, sheep and the like through denaturation and degradation, contains more than 8L-type amino acids, is pure protein, does not contain fat and cholesterol, is easy to be absorbed by human bodies, and has certain curative effect on certain diseases, especially has ideal nutritive value for the development of children. The sweet almond oil soft capsule has richer nutrition and is easier to be absorbed by human body by adopting edible gelatin.
The invention also does not limit the proportion of the gelatin and the glycerol in the capsule shell, and preferably, the mass ratio of the gelatin to the glycerol is (5-10): (2-4). The capsule shell is not easy to break under the above proportion, and can be uniformly released and absorbed by human body after being ingested by human body.
In addition, in an embodiment of the present invention, the capsule shell further includes starch, and the starch is used as a disintegrating agent for accelerating the disintegrating speed of the capsule shell of the sweet almond oil soft capsule, so that the sweet almond oil soft capsule can be rapidly disintegrated after entering a human body, and release nutrients to be absorbed by the human body. And the starch is used as a natural disintegrating agent and is harmless to human bodies.
Furthermore, the capsule shell is made of organic calcium, after the sweet almond oil soft capsule enters a human body, the capsule shell is dissolved to release sweet almond oil and omega-3 fatty acid, and under the catalysis of related enzymes in the human body, the organic calcium can be combined with the sweet almond oil and the omega-3 fatty acid to supplement the fatty acid and calcium required by the human body, so that the nutrition is richer.
Preferably, the sweet almond oil is cold-pressed sweet almond oil. The cold pressing method generally requires processing at a temperature below 60 ℃, and the nutritional ingredients are most completely retained because the nutritional ingredients are not damaged and generally do not need to be added with additives, so that the nutritional ingredients can be stored for a long time.
Referring to fig. 1, the present invention further provides a method for preparing the sweet almond oil soft capsule, which comprises the following steps:
and S10, soaking and swelling gelatin in water, adding other raw materials of the capsule shell, stirring uniformly, and performing vacuum defoamation to obtain a mixture.
Preferably, in the step, the vacuum degree of the vacuum defoaming is-0.06 to-0.07 MPa, and the defoaming effect is good within the vacuum degree range.
In addition, the vacuum defoaming time is preferably 1-2 h, and the defoaming effect is good within the defoaming time.
It is understood that the vacuum degree and the time of the vacuum deaeration can be satisfied by both of them, or by only one of them, and as a preferred embodiment of the present invention, the both of them are satisfied at the same time, and the deaeration effect is the best.
It should be noted that other raw materials of the capsule shell comprise essential components of glycerol and omega-3 fatty acid, and can also comprise other optional components of starch and organic calcium.
S20, pressing the mixture at 70-80 ℃ to prepare a soft film.
Specifically, this step may operate as follows:
and (3) coating the mixture on the surface of a flat plate to enable the thickness to be uniform, and heating at 70-80 ℃ to enable surface moisture to evaporate to form a soft film with certain elasticity.
S30, pressing the soft capsule, the sweet almond oil and the linseed oil into soft capsules.
The steps can be carried out in an automatic rotary capsule rolling machine, the sweet almond oil used by the invention can be purchased from the market or can be prepared, and the preparation method comprises the following steps:
s31, soaking the sweet almonds in water, rubbing the sweet almonds into skins, and cleaning the skins to obtain peeled sweet almonds;
s32, drying the peeled sweet almonds at 40-60 ℃, and performing cold pressing to obtain crude oil;
s33, filtering and refining the crude oil to obtain the sweet almond oil.
Preferably, the temperature during cold pressing is 40-50 ℃, and in the temperature range, the nutrient components are completely reserved and the nutrition is rich.
The preparation method of the sweet almond oil soft capsule provided by the invention is simple and convenient, is convenient to operate, has all the beneficial effects of the sweet almond oil soft capsule, and is not repeated herein.
An example of the method for preparing the sweet almond oil soft capsule proposed by the present invention is given below:
(1) soaking edible gelatin in water for swelling, and adding other raw materials (glycerol, omega-3 fatty acid, starch and organic calcium) of the capsule shell, wherein the mass ratio of the gelatin to the glycerol is (5-10): (2-4), after uniformly stirring, defoaming in vacuum for 1-2 h under the vacuum degree of-0.06 to-0.07 MPa to obtain a mixture;
(2) pressing the mixture at 70-80 ℃ to prepare a soft film;
(3) soaking sweet almonds in water, then rubbing the soaked sweet almonds into skins, cleaning the skins to obtain peeled sweet almonds, drying the peeled sweet almonds at 40-60 ℃, carrying out cold pressing at 40-50 ℃ to obtain crude oil, and filtering and refining the crude oil to obtain sweet almond oil;
(4) pressing the soft capsule, sweet almond oil and linseed oil into a soft capsule, wherein the mass ratio of the sweet almond oil to the omega-3 fatty acid is (30-45): 1, the mass ratio of the sweet almond oil to the linseed oil is 1: (0.5 to 4).
The technical solutions of the present invention are further described in detail with reference to the following specific examples, which should be understood as merely illustrative and not limitative.
Example 1
(1) Soaking edible gelatin in water to swell, adding other raw materials (glycerol, eicosapentaenoic acid, starch and organic calcium) of the capsule shell, wherein the mass ratio of the gelatin to the glycerol is 5: 4, stirring uniformly, and then defoaming in vacuum for 1h under the vacuum degree of-0.06 MPa to obtain a mixture;
(2) pressing the mixture at 70 ℃ to prepare a soft film;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 40 deg.C, cold pressing at 40 deg.C to obtain crude oil, filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into the soft capsule, wherein the mass ratio of the sweet almond oil to the eicosapentaenoic acid is 30: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: 0.5.
example 2
(1) Soaking edible gelatin in water to swell, adding other raw materials (glycerol, eicosapentaenoic acid, docosahexaenoic acid, starch and organic calcium) of the capsule shell, wherein the mass ratio of the gelatin to the glycerol is 10: 2, after uniformly stirring, defoaming in vacuum for 2 hours under the vacuum degree of-0.07 MPa to obtain a mixture;
(2) pressing the mixture at 80 ℃ to form a soft film;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 60 deg.C, cold pressing at 50 deg.C to obtain crude oil, and filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into the soft capsule, wherein the mass ratio of the sweet almond oil to the eicosapentaenoic acid and the docosahexaenoic acid is 45: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: 1.
example 3
(1) Soaking edible gelatin in water to swell, and adding other raw materials (glycerol, linolenic acid, starch and organic calcium) of the capsule shell, wherein the mass ratio of the gelatin to the glycerol is 7: 3, after uniformly stirring, defoaming in vacuum for 1h under the vacuum degree of-0.07 MPa to obtain a mixture;
(2) pressing the mixture at 75 ℃ to form a soft film;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 50 deg.C, cold pressing at 45 deg.C to obtain crude oil, and filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into a soft capsule, wherein the mass ratio of the sweet almond oil to the linolenic acid is 38: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: 2.
example 4
(1) Soaking edible gelatin in water to swell, adding other materials (glycerol, linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, starch, organic calcium) of capsule shell, wherein the mass ratio of gelatin to glycerol is 8: 3, after uniformly stirring, defoaming in vacuum for 2 hours under the vacuum degree of-0.06 MPa to obtain a mixture;
(2) pressing the mixture at 72 ℃ to form a soft film;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 45 deg.C, cold pressing at 48 deg.C to obtain crude oil, and filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into the soft capsule, wherein the mass ratio of the sweet almond oil to the substances of linolenic acid, eicosapentaenoic acid and docosahexaenoic acid is 37: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: 3.
example 5
(1) Soaking edible gelatin in water to swell, adding other raw materials (glycerol, docosahexaenoic acid, starch and organic calcium) of capsule shell, wherein the mass ratio of gelatin to glycerol is 5: 2, after uniformly stirring, defoaming in vacuum for 1h under the vacuum degree of-0.07 MPa to obtain a mixture;
(2) pressing the mixture at 79 ℃ to form a soft film;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 55 deg.C, cold pressing at 44 deg.C to obtain crude oil, and filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into a soft capsule, wherein the mass ratio of the sweet almond oil to the docosahexaenoic acid is 35: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: (0.5-4) the mass ratio of the sweet almond oil to the linseed oil is 1: 4.
example 6
(1) Soaking edible gelatin in water to swell, adding other materials (glycerol, eicosapentaenoic acid, and docosahexaenoic acid) of capsule shell, wherein the mass ratio of gelatin to glycerol is 9: 3, after uniformly stirring, defoaming in vacuum for 2 hours under the vacuum degree of-0.07 MPa to obtain a mixture;
(2) pressing the mixture at 76 deg.C to obtain soft capsule;
(3) soaking sweet almond in water, peeling, cleaning to obtain peeled sweet almond, oven drying at 55 deg.C, cold pressing at 48 deg.C to obtain crude oil, and filtering and refining to obtain sweet almond oil;
(4) and pressing the soft capsule, the sweet almond oil and the linseed oil into the soft capsule, wherein the mass ratio of the sweet almond oil to the eicosapentaenoic acid and the docosahexaenoic acid is 40: 1, the mass ratio of the sweet almond oil to the linseed oil is 1: 3.5.
comparative example 1
The procedure was the same as in example 1 except that the omega-3 fatty acid (eicosapentaenoic acid) was not added.
Comparative example 2
The procedure was the same as in example 1 except that no linseed oil was added.
The following tests were carried out for examples 1 to 6 and comparative examples 1 to 2:
the test consisted of 35 healthy volunteers, and 35 volunteers were randomly divided into 7 groups of 5 persons each, corresponding to the administration of the same dose of the sweet almond oil software capsules of examples 1 to 6 and comparative examples 1 to 2 per day, and after 30 days, the BMI (body mass index) and the total content of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) in the blood of the volunteers were measured, to obtain table 1.
TABLE 1 influence of examples 1-6 and comparative example 1 on human growth
Referring to table 1, it can be seen that the sweet almond oil soft capsules provided by the embodiments of the present invention can effectively regulate the dynamic balance of human body, regulate the mass ratio of human body to be in the middle most healthy state, improve the body quality of human body, and increase the content of omega-3 fatty acids in blood, but the comparative example 1 without adding omega-3 fatty acids, and the comparative example 2 without adding linseed oil, the regulating effect on human body mass index and the content of omega-3 fatty acids in body are both less than those of the embodiments 1 to 6, which shows that the addition of the omega-3 fatty acids and linseed oil of the present invention can interact with linoleic acid in sweet almond oil, regulate the growth and development of human body, and maintain the dynamic balance in human body.
In conclusion, the sweet almond oil soft capsule provided by the invention has balanced nutrition, is beneficial to the growth and development of human bodies, and can maintain the dynamic balance in the human bodies.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention, and all modifications and equivalents of the present invention, which are made by the contents of the present specification and the accompanying drawings, or directly/indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (10)
1. The sweet almond oil soft capsule is characterized by comprising a capsule shell and an inclusion compound wrapped in the capsule shell, wherein the capsule shell is made of gelatin, glycerol and omega-3 fatty acid, and the inclusion compound comprises sweet almond oil and linseed oil.
2. The sweet almond oil soft capsule of claim 1, wherein the amount ratio of the sweet almond oil to the omega-3 fatty acid material is (30-45): 1.
3. the sweet almond oil soft capsule of claim 1, wherein the omega-3 fatty acids comprise at least one of linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid.
4. The sweet almond oil soft capsule of claim 1, wherein the gelatin is an edible gelatin; and/or the presence of a gas in the gas,
the mass ratio of the gelatin to the glycerol is (5-10): (2-4).
5. The sweet almond oil soft capsule of claim 1, wherein the shell material further comprises starch; and/or the presence of a gas in the gas,
the capsule shell also comprises organic calcium.
6. The sweet almond oil soft capsule of claim 1, wherein the sweet almond oil is cold-pressed sweet almond oil.
7. A method for preparing the sweet almond oil soft capsule as claimed in any one of claims 1 to 6, characterized by comprising the following steps:
s10, putting the gelatin into water to be soaked and expanded, adding other raw materials of the capsule shell, stirring uniformly, and performing vacuum defoamation to obtain a mixture;
s20, pressing the mixture at 70-80 ℃ to prepare a soft film;
s30, pressing the soft capsule, the sweet almond oil and the linseed oil into soft capsules.
8. The method for preparing a sweet almond oil soft capsule as claimed in claim 7, wherein in step S10, the degree of vacuum of the vacuum defoamation is-0.06 to-0.07 MPa; and/or the presence of a gas in the gas,
the vacuum defoaming time is 1-2 h.
9. The method for preparing a sweet almond oil soft capsule according to claim 7, wherein in step S30, the sweet almond oil is prepared by the following method:
s31, soaking the sweet almonds in water, rubbing the sweet almonds into skins, and cleaning the skins to obtain peeled sweet almonds;
s32, drying the peeled sweet almonds at 40-60 ℃, and performing cold pressing to obtain crude oil;
s33, filtering and refining the crude oil to obtain the sweet almond oil.
10. The method for preparing the sweet almond oil soft capsule as claimed in claim 9, wherein the cold pressing temperature is 40-50 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110952829.1A CN113854562A (en) | 2021-08-20 | 2021-08-20 | Soft capsule of sweet almond oil and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110952829.1A CN113854562A (en) | 2021-08-20 | 2021-08-20 | Soft capsule of sweet almond oil and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113854562A true CN113854562A (en) | 2021-12-31 |
Family
ID=78990648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110952829.1A Pending CN113854562A (en) | 2021-08-20 | 2021-08-20 | Soft capsule of sweet almond oil and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113854562A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1386501A (en) * | 2001-05-23 | 2002-12-25 | 上海展望集团有限公司 | Omega-3 fatty acid capsule |
| CN101279049A (en) * | 2007-04-06 | 2008-10-08 | 王洪飞 | Soft capsules for resisting altitude stress |
| CN101284122A (en) * | 2007-04-06 | 2008-10-15 | 王洪飞 | Soft capsules for resisting the climate sickness |
| CN101773276A (en) * | 2009-05-07 | 2010-07-14 | 李建宏 | Sweet almond oil soft capsule and preparation method thereof |
| CN103202351A (en) * | 2013-04-23 | 2013-07-17 | 山东省恒兴油脂有限公司 | Functional grease composition and preparation method thereof |
| CN104055123A (en) * | 2014-05-25 | 2014-09-24 | 宁波市成大机械研究所 | Gamma-linolenic acid containing deep sea fish oil soft capsule |
| JP2016033119A (en) * | 2014-07-31 | 2016-03-10 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | Capsule formulation |
-
2021
- 2021-08-20 CN CN202110952829.1A patent/CN113854562A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1386501A (en) * | 2001-05-23 | 2002-12-25 | 上海展望集团有限公司 | Omega-3 fatty acid capsule |
| CN101279049A (en) * | 2007-04-06 | 2008-10-08 | 王洪飞 | Soft capsules for resisting altitude stress |
| CN101284122A (en) * | 2007-04-06 | 2008-10-15 | 王洪飞 | Soft capsules for resisting the climate sickness |
| CN101773276A (en) * | 2009-05-07 | 2010-07-14 | 李建宏 | Sweet almond oil soft capsule and preparation method thereof |
| CN103202351A (en) * | 2013-04-23 | 2013-07-17 | 山东省恒兴油脂有限公司 | Functional grease composition and preparation method thereof |
| CN104055123A (en) * | 2014-05-25 | 2014-09-24 | 宁波市成大机械研究所 | Gamma-linolenic acid containing deep sea fish oil soft capsule |
| JP2016033119A (en) * | 2014-07-31 | 2016-03-10 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | Capsule formulation |
Non-Patent Citations (1)
| Title |
|---|
| 孙树侠, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2275060C (en) | Novel triglyceride and composition comprising the same | |
| EP1681945B1 (en) | Human breast milk lipid mimetic as dietary supplement | |
| US5550156A (en) | Microbial oil mixtures and uses thereof | |
| ES2661674T3 (en) | Method of producing fat or microbial oil that has a reduced content of non-saponifiable matter and said fat or oil | |
| CN111134334A (en) | Probiotic microcapsule soft particles and preparation method thereof | |
| CN101305752B (en) | Production method of human milk fat substituted grease | |
| CN108606135A (en) | A kind of low-sugar type DHA algal oil gel candy and preparation method thereof | |
| CN111084381A (en) | Ketogenic nutritional meal replacement powder and application | |
| CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
| CN108741029A (en) | High fat diet nutrient powder and preparation method thereof | |
| CN106659220A (en) | Nutritional composition | |
| CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
| CN109337939A (en) | A kind of preparation method of polyunsaturated fatty acid structured lipid | |
| CN112772924A (en) | Special grease base oil for functional food and preparation method and application thereof | |
| CN108354175A (en) | Composition for relieving asthenopia containing flake, theanine and γ-aminobutyric acid | |
| Tereshchuk | Theoretical and practical aspects of the development of a balanced lipid complex of fat compositions | |
| CN108185427A (en) | Composition for relieving asthenopia containing flake, theanine and phosphatidylserine | |
| Man et al. | Medium-chain triacylglycerols | |
| CN113854562A (en) | Soft capsule of sweet almond oil and preparation method | |
| CN112006113A (en) | Blend oil for regulating blood pressure and reducing blood fat and preparation method thereof | |
| JP5096658B2 (en) | Soft capsule with improved bioavailability | |
| CN111743996A (en) | Oral emulsion for improving memory and senile dementia and preparation method thereof | |
| CN109845840A (en) | The preparation method of saturated fatty acid and middle long chain fatty acids structured lipid | |
| CN110269133A (en) | It is a kind of to improve diet feed of polyunsaturated fatty acid and preparation method thereof and purposes in mutton sheep body | |
| CN110037306A (en) | Backbone lipid composition and its preparation method and application in a kind of liver protection eyeshield |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211231 |
|
| RJ01 | Rejection of invention patent application after publication |